Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangluyi Cai

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 4, 2025
Comment on "Gas Bubbles From Biodegradable Magnesium Implants Convey Mechanical Cues and Promote Immune Cell Stimulation"Chunyuan Guo, Lian Cui, Jiangluyi Cai, et al.
Frontiers in Pharmacology|November 22, 2021
Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and PathogenesisJiangluyi Cai, Lian Cui, Yu Wang, et al.
Signal Transduction and Targeted Therapy|September 22, 2022
RNA modifications: importance in immune cell biology and related diseasesLian Cui, Rui Ma, Jiangluyi Cai, et al.
Frontiers in Medicine|April 10, 2026
Development and validation of a prediction model for primary non-response to IL-17A inhibitors in psoriasisQian Yu, Yuxiong Jiang, Yifan Hu, et al.
International Journal of Biological Sciences|June 22, 2026
Comprehensive Metabolomic Profiling of Skin Lesions from Psoriasis Patients Reveals Disease SignaturesPeiyao Zhu, Yuanyuan Wang, Jie Sun, et al.
Frontiers in Immunology|February 28, 2024
Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANESRui Ma, Lian Cui, Jiangluyi Cai, et al.
Frontiers in Immunology|April 13, 2026
Baseline Th17/Tc17 and LAG-3 levels serve as candidate exploratory markers for early ixekizumab response in psoriasisNan Yang, Zeyu Chen, Yuxiong Jiang, et al.
International Immunopharmacology|November 16, 2025
Cryptochrome 2 stabilization alleviates psoriasis by inhibiting keratinocyte hyperproliferation and inflammationLingling Yao, Lian Cui, Qianyu Chen, et al.
Drugs|June 24, 2026
Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug ReactionsYue Yin, Yuanyuan Wang, Jing Zhou, et al.
Cell & Bioscience|January 6, 2026
IL-27 signaling mediates skin inflammation in experimental psoriasis and atopic dermatitisZeyu Chen, Lian Cui, Zhiyi Lan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 4, 2025
Comment on "Gas Bubbles From Biodegradable Magnesium Implants Convey Mechanical Cues and Promote Immune Cell Stimulation"Chunyuan Guo, Lian Cui, Jiangluyi Cai, et al.
Frontiers in Pharmacology|November 22, 2021
Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and PathogenesisJiangluyi Cai, Lian Cui, Yu Wang, et al.
Signal Transduction and Targeted Therapy|September 22, 2022
RNA modifications: importance in immune cell biology and related diseasesLian Cui, Rui Ma, Jiangluyi Cai, et al.
Frontiers in Medicine|April 10, 2026
Development and validation of a prediction model for primary non-response to IL-17A inhibitors in psoriasisQian Yu, Yuxiong Jiang, Yifan Hu, et al.
International Journal of Biological Sciences|June 22, 2026
Comprehensive Metabolomic Profiling of Skin Lesions from Psoriasis Patients Reveals Disease SignaturesPeiyao Zhu, Yuanyuan Wang, Jie Sun, et al.
Frontiers in Immunology|February 28, 2024
Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANESRui Ma, Lian Cui, Jiangluyi Cai, et al.
Frontiers in Immunology|April 13, 2026
Baseline Th17/Tc17 and LAG-3 levels serve as candidate exploratory markers for early ixekizumab response in psoriasisNan Yang, Zeyu Chen, Yuxiong Jiang, et al.
International Immunopharmacology|November 16, 2025
Cryptochrome 2 stabilization alleviates psoriasis by inhibiting keratinocyte hyperproliferation and inflammationLingling Yao, Lian Cui, Qianyu Chen, et al.
Drugs|June 24, 2026
Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug ReactionsYue Yin, Yuanyuan Wang, Jing Zhou, et al.
Cell & Bioscience|January 6, 2026
IL-27 signaling mediates skin inflammation in experimental psoriasis and atopic dermatitisZeyu Chen, Lian Cui, Zhiyi Lan, et al.
Pageof 2